ASPH and neoplasm: This broad immunostimulatory effect supports the potential of ASPH inhibition as part of combination therapies for tumors with various levels of MHC-I expression and different mechanisms of MHC-I downregulation.61–64 Given its ability to suppress tumor growth and metastasis, ASPH inhibition merits further investigation in clinical trials, particularly in combination with immunotherapy.